Innovative. Transformative. Disruptive. Affordable.
GeneStore's ITDA strategy strives to enable ‘innovative’ in-vitro diagnostic (IVD) solutions for infectious diseases that bring about healthcare ‘transformations’ that are both ‘disruptive’ and ‘affordable’ from a global stand-point.
It is this strategy that is behind GeneStore's Disruption during the COVID-19 pandemic and flawless manufacturing experience of over 5 million kits manufactured.